Stay updated on CHF 6333 Safety in CF and NCFB Clinical Trial
Sign up to get notified when there's something new on the CHF 6333 Safety in CF and NCFB Clinical Trial page.

Latest updates to the CHF 6333 Safety in CF and NCFB Clinical Trial page
- CheckyesterdayChange DetectedThe record describes a completed Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of inhaled CHF 6333 in adults with cystic fibrosis or non-cystic fibrosis bronchiectasis.SummaryDifference52%

- Check8 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the study page still displays a 403 Forbidden error.SummaryDifference0.3%

- Check15 days agoChange DetectedA banner announces NIH website changes and explains that some NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check22 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.1 instead of v3.7.0; the page remains a 403 error.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page shows an updated site revision (Revision: v3.7.0) replacing the previous version; this update appears to be a general site upgrade rather than a modification to the study details or data.SummaryDifference20%

Stay in the know with updates to CHF 6333 Safety in CF and NCFB Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CHF 6333 Safety in CF and NCFB Clinical Trial page.